Dupilumab Improves Patient-Reported Outcomes As Early As 1 Month Among Adults With Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study. J of Skin 2024, 8 (6), s506. https://doi.org/10.25251/skin.8.supp.506.